Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Cantargia AB
CANTACurrent price
1.92 SEK
+0.027 SEK (+1.43%)
Last closed
1.89 SEK
Company
www.cantargia.com
ISIN
SE0006371126
Sector
Healthcare
Industry
Biotechnology
Exchange
Stockholm Exchange
Capitalization
358 033 865 SEK
Yield for 12 month
-49.10 %
1Y
3Y
5Y
10Y
15Y
CANTA
Cantargia AB (publ), a biotechnology company, develops antibody-based treatments for life threatening diseases. The company is developing CAN04 (nadunolimab), an interleukin-1 receptor accessory protein (IL1RAP) binding antibody, which is in Phase II clinical trial for the treatment of pancreatic cancer, non-small cell lung cancer, and triple-negative breast cancer; and CAN10, an antibody against IL1RAP, which is in preclinical phase for the treatment of autoimmune and inflammatory diseases, including systemic sclerosis and myocarditis. It also develops CANxx, an IL1RAP-based antibody platform. The company has collaboration agreements with Patheon Biologics B.V. and BioWa Inc. for the manufacture and production of CAN04; and GEICAM, Spanish breast cancer group. Cantargia AB (publ) was incorporated in 2009 and is based in Lund, Sweden. Address: Ideon Gateway, Lund, Sweden, 223 63
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
106.82 SEKP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-3 505 220 SEK
Last Year
-3 750 014 SEK
Current Quarter
-875 542 SEK
Last Quarter
-874 529 SEK
Key Figures CANTA
1 year
3 years
5 years
10 years
EBITDA
-235 462 426 SEK
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-63.46 %
PEG Ratio
–
Return On Equity TTM
-130.14 %
Wall Street Target Price
106.82 SEK
Revenue TTM
–
Book Value
0.5 SEK
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-1.32 SEK
Diluted Eps TTM
-1.32 SEK
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics CANTA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CANTA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1615:1344
Payout Ratio
–
Last Split Date
22.07.2022
Dividend Date
–
Stock Valuation CANTA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
2.742
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-1.574
Price Book MRQ
3.8907
Financials CANTA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CANTA
For 52 weeks
1.91 SEK
5.28 SEK
50 Day MA
3.38 SEK
Shares Short Prior Month
–
200 Day MA
3.69 SEK
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart